Citrini Bets on Life Sciences After Claude AI Drug Study
Life sciences companies stand to gain from a surge in artificial intelligence fueled drug discovery, says Citrini Research after testing Anthropic PBC’s Claude Science.
Read the full story at Bloomberg AI ↗
Timeline · 1 report
- 2026-10-20 13:00 · Bloomberg AI
Citrini Bets on Life Sciences After Claude AI Drug Study